HEADER HYDROLASE 09-APR-08 2JJK TITLE FRUCTOSE-1,6-BISPHOSPHATASE(D-FRUCTOSE-1,6-BISPHOSPHATE TITLE 2 -1-PHOSPHOHYDROLASE) (E.C.3.1.3.11) COMPLEXED WITH A TITLE 3 DUAL BINDING AMP SITE INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: FRUCTOSE-1,6-BISPHOSPHATASE 1; COMPND 3 CHAIN: A, B, C, D; COMPND 4 SYNONYM: D-FRUCTOSE-1,6- BISPHOSPHATE 1-PHOSPHOHYDROLASE COMPND 5 1, FBPASE 1; COMPND 6 EC: 3.1.3.11; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 TISSUE: LIVER; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET KEYWDS HYDROLASE (PHOSPHORIC MONOESTER), DISEASE MUTATION, KEYWDS 2 ALLOSTERIC ENZYME, ZINC, HYDROLASE, POLYMORPHISM, KEYWDS 3 GLUCONEOGENESIS, CARBOHYDRATE METABOLISM EXPDTA X-RAY DIFFRACTION AUTHOR A.RUF,C.JOSEPH,J.BENZ,B.FOL,T.TETAZ,P.HEBEISEN REVDAT 4 24-FEB-09 2JJK 1 VERSN REVDAT 3 19-AUG-08 2JJK 1 JRNL REVDAT 2 05-AUG-08 2JJK 1 JRNL REVDAT 1 22-JUL-08 2JJK 0 JRNL AUTH P.HEBEISEN,B.KUHN,P.KOHLER,M.GUBLER,W.HUBER, JRNL AUTH 2 E.KITAS,B.SCHOTT,J.BENZ,C.JOSEPH,A.RUF JRNL TITL ALLOSTERIC FBPASE INHIBITORS GAIN 10(5) TIMES IN JRNL TITL 2 POTENCY WHEN SIMULTANEOUSLY BINDING TWO JRNL TITL 3 NEIGHBORING AMP SITES. JRNL REF BIOORG.MED.CHEM.LETT. V. 18 4708 2008 JRNL REFN ISSN 0960-894X JRNL PMID 18650089 JRNL DOI 10.1016/J.BMCL.2008.06.103 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.4.0067 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 28.88 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 89.9 REMARK 3 NUMBER OF REFLECTIONS : 90267 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.216 REMARK 3 R VALUE (WORKING SET) : 0.213 REMARK 3 FREE R VALUE : 0.266 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 4767 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.05 REMARK 3 REFLECTION IN BIN (WORKING SET) : 6720 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2680 REMARK 3 BIN FREE R VALUE SET COUNT : 354 REMARK 3 BIN FREE R VALUE : 0.3360 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 9729 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 84 REMARK 3 SOLVENT ATOMS : 1082 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 24.32 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.71000 REMARK 3 B22 (A**2) : -0.56000 REMARK 3 B33 (A**2) : -0.15000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.217 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.195 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.150 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 5.385 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.929 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.889 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 9989 ; 0.013 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 13488 ; 1.391 ; 1.999 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 1263 ; 5.948 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 384 ;37.823 ;24.375 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1777 ;16.147 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 48 ;17.056 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 1532 ; 0.093 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 7388 ; 0.006 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 6307 ; 0.750 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 10153 ; 1.314 ; 2.000 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 3682 ; 2.175 ; 3.000 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 3335 ; 3.363 ; 4.500 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : 2 REMARK 3 REMARK 3 NCS GROUP NUMBER : 1 REMARK 3 CHAIN NAMES : A B C D REMARK 3 NUMBER OF COMPONENTS NCS GROUP : 1 REMARK 3 COMPONENT C SSSEQI TO C SSSEQI CODE REMARK 3 1 A 1 A 500 5 REMARK 3 1 B 1 B 500 5 REMARK 3 1 C 1 C 500 5 REMARK 3 1 D 1 D 500 5 REMARK 3 GROUP CHAIN COUNT RMS WEIGHT REMARK 3 MEDIUM POSITIONAL 1 A (A): 1268 ; 0.30 ; 0.50 REMARK 3 MEDIUM POSITIONAL 1 B (A): 1268 ; 0.36 ; 0.50 REMARK 3 MEDIUM POSITIONAL 1 C (A): 1268 ; 0.33 ; 0.50 REMARK 3 MEDIUM POSITIONAL 1 D (A): 1268 ; 0.35 ; 0.50 REMARK 3 LOOSE POSITIONAL 1 A (A): 1158 ; 0.59 ; 5.00 REMARK 3 LOOSE POSITIONAL 1 B (A): 1158 ; 0.71 ; 5.00 REMARK 3 LOOSE POSITIONAL 1 C (A): 1158 ; 0.71 ; 5.00 REMARK 3 LOOSE POSITIONAL 1 D (A): 1158 ; 0.71 ; 5.00 REMARK 3 MEDIUM THERMAL 1 A (A**2): 1268 ; 2.76 ; 2.00 REMARK 3 MEDIUM THERMAL 1 B (A**2): 1268 ; 1.61 ; 2.00 REMARK 3 MEDIUM THERMAL 1 C (A**2): 1268 ; 1.59 ; 2.00 REMARK 3 MEDIUM THERMAL 1 D (A**2): 1268 ; 2.30 ; 2.00 REMARK 3 LOOSE THERMAL 1 A (A**2): 1158 ; 3.15 ; 10.00 REMARK 3 LOOSE THERMAL 1 B (A**2): 1158 ; 2.25 ; 10.00 REMARK 3 LOOSE THERMAL 1 C (A**2): 1158 ; 2.39 ; 10.00 REMARK 3 LOOSE THERMAL 1 D (A**2): 1158 ; 2.90 ; 10.00 REMARK 3 REMARK 3 NCS GROUP NUMBER : 2 REMARK 3 CHAIN NAMES : A D REMARK 3 NUMBER OF COMPONENTS NCS GROUP : 1 REMARK 3 COMPONENT C SSSEQI TO C SSSEQI CODE REMARK 3 1 A 1336 A 1336 4 REMARK 3 1 D 1336 D 1336 4 REMARK 3 GROUP CHAIN COUNT RMS WEIGHT REMARK 3 MEDIUM POSITIONAL 2 A (A): 42 ; 0.09 ; 0.50 REMARK 3 MEDIUM POSITIONAL 2 D (A): 42 ; 0.09 ; 0.50 REMARK 3 MEDIUM THERMAL 2 A (A**2): 42 ; 0.73 ; 2.00 REMARK 3 MEDIUM THERMAL 2 D (A**2): 42 ; 0.73 ; 2.00 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE REMARK 3 RIDING POSITIONS. REMARK 4 REMARK 4 2JJK COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 10-APR-08. REMARK 100 THE PDBE ID CODE IS EBI-35891. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 14-JUL-06 REMARK 200 TEMPERATURE (KELVIN) : 120 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X10SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 95035 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.00 REMARK 200 RESOLUTION RANGE LOW (A) : 30.00 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.0 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 88.5 REMARK 200 DATA REDUNDANCY : 5.1 REMARK 200 R MERGE (I) : 0.14 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 8.60 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.11 REMARK 200 COMPLETENESS FOR SHELL (%) : 83.8 REMARK 200 DATA REDUNDANCY IN SHELL : 3.9 REMARK 200 R MERGE FOR SHELL (I) : 0.36 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 4.50 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.08 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.53 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: RESERVOIR = 0.1M HEPES PH7.0, REMARK 280 0.1M AMMONIUM ACETATE, 12% PEG 3350 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 33.58800 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 138.61700 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 41.50600 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 138.61700 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 33.58800 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 41.50600 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 TOTAL BURIED SURFACE AREA: 19470 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 54400 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -95.2 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 0 REMARK 465 ALA A 1 REMARK 465 ASP A 2 REMARK 465 GLN A 3 REMARK 465 ALA A 4 REMARK 465 PRO A 5 REMARK 465 PHE A 6 REMARK 465 ASP A 7 REMARK 465 THR A 8 REMARK 465 SER A 62 REMARK 465 THR A 63 REMARK 465 ASN A 64 REMARK 465 VAL A 65 REMARK 465 THR A 66 REMARK 465 GLY A 67 REMARK 465 ASP A 68 REMARK 465 GLN A 69 REMARK 465 GLN A 337 REMARK 465 MET B 0 REMARK 465 ALA B 1 REMARK 465 ASP B 2 REMARK 465 GLN B 3 REMARK 465 ALA B 4 REMARK 465 PRO B 5 REMARK 465 PHE B 6 REMARK 465 ASP B 7 REMARK 465 THR B 8 REMARK 465 SER B 62 REMARK 465 THR B 63 REMARK 465 ASN B 64 REMARK 465 VAL B 65 REMARK 465 THR B 66 REMARK 465 GLY B 67 REMARK 465 ASP B 68 REMARK 465 GLN B 69 REMARK 465 VAL B 70 REMARK 465 LYS B 71 REMARK 465 GLN B 337 REMARK 465 MET C 0 REMARK 465 ALA C 1 REMARK 465 ASP C 2 REMARK 465 GLN C 3 REMARK 465 ALA C 4 REMARK 465 PRO C 5 REMARK 465 PHE C 6 REMARK 465 ASP C 7 REMARK 465 THR C 8 REMARK 465 SER C 62 REMARK 465 THR C 63 REMARK 465 ASN C 64 REMARK 465 VAL C 65 REMARK 465 THR C 66 REMARK 465 GLY C 67 REMARK 465 ASP C 68 REMARK 465 GLN C 69 REMARK 465 VAL C 70 REMARK 465 GLN C 337 REMARK 465 MET D 0 REMARK 465 ALA D 1 REMARK 465 ASP D 2 REMARK 465 GLN D 3 REMARK 465 ALA D 4 REMARK 465 PRO D 5 REMARK 465 PHE D 6 REMARK 465 ASP D 7 REMARK 465 THR D 8 REMARK 465 SER D 62 REMARK 465 THR D 63 REMARK 465 ASN D 64 REMARK 465 VAL D 65 REMARK 465 THR D 66 REMARK 465 GLY D 67 REMARK 465 ASP D 68 REMARK 465 GLN D 69 REMARK 465 VAL D 70 REMARK 465 LYS D 71 REMARK 465 GLN D 337 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ALA A 336 CA C O CB REMARK 470 ALA B 336 CA C O CB REMARK 470 ALA C 336 CA C O CB REMARK 470 ALA D 336 CA C O CB REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 NH2 ARG C 140 - O HOH C 2137 2.16 REMARK 500 O HOH D 2023 - O HOH D 2052 2.20 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LEU B 33 CA - CB - CG ANGL. DEV. = 15.9 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 50 34.97 72.81 REMARK 500 ASN A 267 -160.42 -126.74 REMARK 500 GLU A 280 -61.75 -121.40 REMARK 500 LYS B 50 32.87 72.82 REMARK 500 CYS B 92 -26.90 -142.05 REMARK 500 SER B 143 156.45 -48.64 REMARK 500 ASP B 178 -39.80 -39.84 REMARK 500 ASN B 267 -146.10 -133.85 REMARK 500 GLU B 280 -64.88 -122.40 REMARK 500 HIS B 334 30.10 -94.07 REMARK 500 LEU C 153 40.45 -93.80 REMARK 500 ASP C 199 56.39 33.73 REMARK 500 LYS C 207 20.46 -147.08 REMARK 500 GLU C 280 -68.51 -120.46 REMARK 500 LYS D 50 30.62 71.58 REMARK 500 PHE D 89 18.85 58.83 REMARK 500 SER D 131 138.92 -38.52 REMARK 500 TYR D 215 32.09 -95.78 REMARK 500 ASP D 235 -155.08 -108.87 REMARK 500 GLU D 280 -60.94 -130.85 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 600 REMARK 600 HETEROGEN REMARK 600 R15: BISULFONYLUREA REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE R15 D1336 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE R15 A1336 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1FTA RELATED DB: PDB REMARK 900 FRUCTOSE-1,6-BISPHOSPHATASE(D-FRUCTOSE-1,6 REMARK 900 -BISPHOSPHATE, 1-PHOSPHOHYDROLASE) COMPLEXED REMARK 900 WITH THE ALLOSTERIC INHIBITOR AMP REMARK 900 RELATED ID: 2FIE RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN LIVER FBPASE COMPLEXED REMARK 900 WITH POTENTBENZOXAZOLE ALLOSTERIC INHIBITORS REMARK 900 RELATED ID: 2FIX RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN LIVER FBPASE COMPLEXED REMARK 900 WITH POTENTBENZOXAZOLE ALLOSTERIC INHIBITIORS REMARK 900 RELATED ID: 2FHY RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN LIVER FPBASE COMPLEXED REMARK 900 WITH A NOVELBENZOXAZOLE AS ALLOSTERIC REMARK 900 INHIBITOR DBREF 2JJK A 0 337 UNP P09467 F16P1_HUMAN 1 338 DBREF 2JJK B 0 337 UNP P09467 F16P1_HUMAN 1 338 DBREF 2JJK C 0 337 UNP P09467 F16P1_HUMAN 1 338 DBREF 2JJK D 0 337 UNP P09467 F16P1_HUMAN 1 338 SEQRES 1 A 338 MET ALA ASP GLN ALA PRO PHE ASP THR ASP VAL ASN THR SEQRES 2 A 338 LEU THR ARG PHE VAL MET GLU GLU GLY ARG LYS ALA ARG SEQRES 3 A 338 GLY THR GLY GLU LEU THR GLN LEU LEU ASN SER LEU CYS SEQRES 4 A 338 THR ALA VAL LYS ALA ILE SER SER ALA VAL ARG LYS ALA SEQRES 5 A 338 GLY ILE ALA HIS LEU TYR GLY ILE ALA GLY SER THR ASN SEQRES 6 A 338 VAL THR GLY ASP GLN VAL LYS LYS LEU ASP VAL LEU SER SEQRES 7 A 338 ASN ASP LEU VAL MET ASN MET LEU LYS SER SER PHE ALA SEQRES 8 A 338 THR CYS VAL LEU VAL SER GLU GLU ASP LYS HIS ALA ILE SEQRES 9 A 338 ILE VAL GLU PRO GLU LYS ARG GLY LYS TYR VAL VAL CYS SEQRES 10 A 338 PHE ASP PRO LEU ASP GLY SER SER ASN ILE ASP CYS LEU SEQRES 11 A 338 VAL SER VAL GLY THR ILE PHE GLY ILE TYR ARG LYS LYS SEQRES 12 A 338 SER THR ASP GLU PRO SER GLU LYS ASP ALA LEU GLN PRO SEQRES 13 A 338 GLY ARG ASN LEU VAL ALA ALA GLY TYR ALA LEU TYR GLY SEQRES 14 A 338 SER ALA THR MET LEU VAL LEU ALA MET ASP CYS GLY VAL SEQRES 15 A 338 ASN CYS PHE MET LEU ASP PRO ALA ILE GLY GLU PHE ILE SEQRES 16 A 338 LEU VAL ASP LYS ASP VAL LYS ILE LYS LYS LYS GLY LYS SEQRES 17 A 338 ILE TYR SER LEU ASN GLU GLY TYR ALA LYS ASP PHE ASP SEQRES 18 A 338 PRO ALA VAL THR GLU TYR ILE GLN ARG LYS LYS PHE PRO SEQRES 19 A 338 PRO ASP ASN SER ALA PRO TYR GLY ALA ARG TYR VAL GLY SEQRES 20 A 338 SER MET VAL ALA ASP VAL HIS ARG THR LEU VAL TYR GLY SEQRES 21 A 338 GLY ILE PHE LEU TYR PRO ALA ASN LYS LYS SER PRO ASN SEQRES 22 A 338 GLY LYS LEU ARG LEU LEU TYR GLU CYS ASN PRO MET ALA SEQRES 23 A 338 TYR VAL MET GLU LYS ALA GLY GLY MET ALA THR THR GLY SEQRES 24 A 338 LYS GLU ALA VAL LEU ASP VAL ILE PRO THR ASP ILE HIS SEQRES 25 A 338 GLN ARG ALA PRO VAL ILE LEU GLY SER PRO ASP ASP VAL SEQRES 26 A 338 LEU GLU PHE LEU LYS VAL TYR GLU LYS HIS SER ALA GLN SEQRES 1 B 338 MET ALA ASP GLN ALA PRO PHE ASP THR ASP VAL ASN THR SEQRES 2 B 338 LEU THR ARG PHE VAL MET GLU GLU GLY ARG LYS ALA ARG SEQRES 3 B 338 GLY THR GLY GLU LEU THR GLN LEU LEU ASN SER LEU CYS SEQRES 4 B 338 THR ALA VAL LYS ALA ILE SER SER ALA VAL ARG LYS ALA SEQRES 5 B 338 GLY ILE ALA HIS LEU TYR GLY ILE ALA GLY SER THR ASN SEQRES 6 B 338 VAL THR GLY ASP GLN VAL LYS LYS LEU ASP VAL LEU SER SEQRES 7 B 338 ASN ASP LEU VAL MET ASN MET LEU LYS SER SER PHE ALA SEQRES 8 B 338 THR CYS VAL LEU VAL SER GLU GLU ASP LYS HIS ALA ILE SEQRES 9 B 338 ILE VAL GLU PRO GLU LYS ARG GLY LYS TYR VAL VAL CYS SEQRES 10 B 338 PHE ASP PRO LEU ASP GLY SER SER ASN ILE ASP CYS LEU SEQRES 11 B 338 VAL SER VAL GLY THR ILE PHE GLY ILE TYR ARG LYS LYS SEQRES 12 B 338 SER THR ASP GLU PRO SER GLU LYS ASP ALA LEU GLN PRO SEQRES 13 B 338 GLY ARG ASN LEU VAL ALA ALA GLY TYR ALA LEU TYR GLY SEQRES 14 B 338 SER ALA THR MET LEU VAL LEU ALA MET ASP CYS GLY VAL SEQRES 15 B 338 ASN CYS PHE MET LEU ASP PRO ALA ILE GLY GLU PHE ILE SEQRES 16 B 338 LEU VAL ASP LYS ASP VAL LYS ILE LYS LYS LYS GLY LYS SEQRES 17 B 338 ILE TYR SER LEU ASN GLU GLY TYR ALA LYS ASP PHE ASP SEQRES 18 B 338 PRO ALA VAL THR GLU TYR ILE GLN ARG LYS LYS PHE PRO SEQRES 19 B 338 PRO ASP ASN SER ALA PRO TYR GLY ALA ARG TYR VAL GLY SEQRES 20 B 338 SER MET VAL ALA ASP VAL HIS ARG THR LEU VAL TYR GLY SEQRES 21 B 338 GLY ILE PHE LEU TYR PRO ALA ASN LYS LYS SER PRO ASN SEQRES 22 B 338 GLY LYS LEU ARG LEU LEU TYR GLU CYS ASN PRO MET ALA SEQRES 23 B 338 TYR VAL MET GLU LYS ALA GLY GLY MET ALA THR THR GLY SEQRES 24 B 338 LYS GLU ALA VAL LEU ASP VAL ILE PRO THR ASP ILE HIS SEQRES 25 B 338 GLN ARG ALA PRO VAL ILE LEU GLY SER PRO ASP ASP VAL SEQRES 26 B 338 LEU GLU PHE LEU LYS VAL TYR GLU LYS HIS SER ALA GLN SEQRES 1 C 338 MET ALA ASP GLN ALA PRO PHE ASP THR ASP VAL ASN THR SEQRES 2 C 338 LEU THR ARG PHE VAL MET GLU GLU GLY ARG LYS ALA ARG SEQRES 3 C 338 GLY THR GLY GLU LEU THR GLN LEU LEU ASN SER LEU CYS SEQRES 4 C 338 THR ALA VAL LYS ALA ILE SER SER ALA VAL ARG LYS ALA SEQRES 5 C 338 GLY ILE ALA HIS LEU TYR GLY ILE ALA GLY SER THR ASN SEQRES 6 C 338 VAL THR GLY ASP GLN VAL LYS LYS LEU ASP VAL LEU SER SEQRES 7 C 338 ASN ASP LEU VAL MET ASN MET LEU LYS SER SER PHE ALA SEQRES 8 C 338 THR CYS VAL LEU VAL SER GLU GLU ASP LYS HIS ALA ILE SEQRES 9 C 338 ILE VAL GLU PRO GLU LYS ARG GLY LYS TYR VAL VAL CYS SEQRES 10 C 338 PHE ASP PRO LEU ASP GLY SER SER ASN ILE ASP CYS LEU SEQRES 11 C 338 VAL SER VAL GLY THR ILE PHE GLY ILE TYR ARG LYS LYS SEQRES 12 C 338 SER THR ASP GLU PRO SER GLU LYS ASP ALA LEU GLN PRO SEQRES 13 C 338 GLY ARG ASN LEU VAL ALA ALA GLY TYR ALA LEU TYR GLY SEQRES 14 C 338 SER ALA THR MET LEU VAL LEU ALA MET ASP CYS GLY VAL SEQRES 15 C 338 ASN CYS PHE MET LEU ASP PRO ALA ILE GLY GLU PHE ILE SEQRES 16 C 338 LEU VAL ASP LYS ASP VAL LYS ILE LYS LYS LYS GLY LYS SEQRES 17 C 338 ILE TYR SER LEU ASN GLU GLY TYR ALA LYS ASP PHE ASP SEQRES 18 C 338 PRO ALA VAL THR GLU TYR ILE GLN ARG LYS LYS PHE PRO SEQRES 19 C 338 PRO ASP ASN SER ALA PRO TYR GLY ALA ARG TYR VAL GLY SEQRES 20 C 338 SER MET VAL ALA ASP VAL HIS ARG THR LEU VAL TYR GLY SEQRES 21 C 338 GLY ILE PHE LEU TYR PRO ALA ASN LYS LYS SER PRO ASN SEQRES 22 C 338 GLY LYS LEU ARG LEU LEU TYR GLU CYS ASN PRO MET ALA SEQRES 23 C 338 TYR VAL MET GLU LYS ALA GLY GLY MET ALA THR THR GLY SEQRES 24 C 338 LYS GLU ALA VAL LEU ASP VAL ILE PRO THR ASP ILE HIS SEQRES 25 C 338 GLN ARG ALA PRO VAL ILE LEU GLY SER PRO ASP ASP VAL SEQRES 26 C 338 LEU GLU PHE LEU LYS VAL TYR GLU LYS HIS SER ALA GLN SEQRES 1 D 338 MET ALA ASP GLN ALA PRO PHE ASP THR ASP VAL ASN THR SEQRES 2 D 338 LEU THR ARG PHE VAL MET GLU GLU GLY ARG LYS ALA ARG SEQRES 3 D 338 GLY THR GLY GLU LEU THR GLN LEU LEU ASN SER LEU CYS SEQRES 4 D 338 THR ALA VAL LYS ALA ILE SER SER ALA VAL ARG LYS ALA SEQRES 5 D 338 GLY ILE ALA HIS LEU TYR GLY ILE ALA GLY SER THR ASN SEQRES 6 D 338 VAL THR GLY ASP GLN VAL LYS LYS LEU ASP VAL LEU SER SEQRES 7 D 338 ASN ASP LEU VAL MET ASN MET LEU LYS SER SER PHE ALA SEQRES 8 D 338 THR CYS VAL LEU VAL SER GLU GLU ASP LYS HIS ALA ILE SEQRES 9 D 338 ILE VAL GLU PRO GLU LYS ARG GLY LYS TYR VAL VAL CYS SEQRES 10 D 338 PHE ASP PRO LEU ASP GLY SER SER ASN ILE ASP CYS LEU SEQRES 11 D 338 VAL SER VAL GLY THR ILE PHE GLY ILE TYR ARG LYS LYS SEQRES 12 D 338 SER THR ASP GLU PRO SER GLU LYS ASP ALA LEU GLN PRO SEQRES 13 D 338 GLY ARG ASN LEU VAL ALA ALA GLY TYR ALA LEU TYR GLY SEQRES 14 D 338 SER ALA THR MET LEU VAL LEU ALA MET ASP CYS GLY VAL SEQRES 15 D 338 ASN CYS PHE MET LEU ASP PRO ALA ILE GLY GLU PHE ILE SEQRES 16 D 338 LEU VAL ASP LYS ASP VAL LYS ILE LYS LYS LYS GLY LYS SEQRES 17 D 338 ILE TYR SER LEU ASN GLU GLY TYR ALA LYS ASP PHE ASP SEQRES 18 D 338 PRO ALA VAL THR GLU TYR ILE GLN ARG LYS LYS PHE PRO SEQRES 19 D 338 PRO ASP ASN SER ALA PRO TYR GLY ALA ARG TYR VAL GLY SEQRES 20 D 338 SER MET VAL ALA ASP VAL HIS ARG THR LEU VAL TYR GLY SEQRES 21 D 338 GLY ILE PHE LEU TYR PRO ALA ASN LYS LYS SER PRO ASN SEQRES 22 D 338 GLY LYS LEU ARG LEU LEU TYR GLU CYS ASN PRO MET ALA SEQRES 23 D 338 TYR VAL MET GLU LYS ALA GLY GLY MET ALA THR THR GLY SEQRES 24 D 338 LYS GLU ALA VAL LEU ASP VAL ILE PRO THR ASP ILE HIS SEQRES 25 D 338 GLN ARG ALA PRO VAL ILE LEU GLY SER PRO ASP ASP VAL SEQRES 26 D 338 LEU GLU PHE LEU LYS VAL TYR GLU LYS HIS SER ALA GLN HET R15 D1336 42 HET R15 A1336 42 HETNAM R15 N,N'-(HEPTANE-1,7-DIYLDICARBAMOYL)BIS(3- HETNAM 2 R15 CHLOROBENZENESULFONAMIDE) FORMUL 5 R15 2(C21 H26 N4 O6 CL2 S2) FORMUL 6 HOH *1082(H2 O1) HELIX 1 1 THR A 12 ALA A 24 1 13 HELIX 2 2 GLY A 28 ARG A 49 1 22 HELIX 3 3 GLY A 52 TYR A 57 1 6 HELIX 4 4 LYS A 72 SER A 87 1 16 HELIX 5 5 GLU A 106 GLU A 108 5 3 HELIX 6 6 GLY A 122 LEU A 129 5 8 HELIX 7 7 SER A 148 LEU A 153 5 6 HELIX 8 8 PRO A 155 LEU A 159 5 5 HELIX 9 9 ASN A 212 PHE A 219 5 8 HELIX 10 10 ASP A 220 PHE A 232 1 13 HELIX 11 11 SER A 247 GLY A 259 1 13 HELIX 12 12 GLU A 280 ALA A 291 1 12 HELIX 13 13 VAL A 302 VAL A 305 5 4 HELIX 14 14 SER A 320 HIS A 334 1 15 HELIX 15 15 THR B 12 ALA B 24 1 13 HELIX 16 16 GLY B 28 ARG B 49 1 22 HELIX 17 17 GLY B 52 TYR B 57 1 6 HELIX 18 18 LYS B 72 SER B 87 1 16 HELIX 19 19 GLU B 106 GLU B 108 5 3 HELIX 20 20 GLY B 122 LEU B 129 5 8 HELIX 21 21 SER B 148 LEU B 153 5 6 HELIX 22 22 PRO B 155 LEU B 159 5 5 HELIX 23 23 ASN B 212 PHE B 219 5 8 HELIX 24 24 ASP B 220 PHE B 232 1 13 HELIX 25 25 SER B 247 GLY B 259 1 13 HELIX 26 26 GLU B 280 ALA B 291 1 12 HELIX 27 27 VAL B 302 VAL B 305 5 4 HELIX 28 28 SER B 320 GLU B 332 1 13 HELIX 29 29 THR C 12 ALA C 24 1 13 HELIX 30 30 GLY C 28 ARG C 49 1 22 HELIX 31 31 GLY C 52 TYR C 57 1 6 HELIX 32 32 LYS C 72 SER C 88 1 17 HELIX 33 33 GLU C 106 GLU C 108 5 3 HELIX 34 34 GLY C 122 LEU C 129 5 8 HELIX 35 35 SER C 148 LEU C 153 5 6 HELIX 36 36 PRO C 155 LEU C 159 5 5 HELIX 37 37 ASN C 212 PHE C 219 5 8 HELIX 38 38 ASP C 220 PHE C 232 1 13 HELIX 39 39 SER C 247 GLY C 259 1 13 HELIX 40 40 GLU C 280 ALA C 291 1 12 HELIX 41 41 VAL C 302 VAL C 305 5 4 HELIX 42 42 SER C 320 HIS C 334 1 15 HELIX 43 43 THR D 12 ALA D 24 1 13 HELIX 44 44 GLY D 28 ARG D 49 1 22 HELIX 45 45 GLY D 52 TYR D 57 1 6 HELIX 46 46 LYS D 72 SER D 88 1 17 HELIX 47 47 GLU D 106 GLU D 108 5 3 HELIX 48 48 GLY D 122 LEU D 129 5 8 HELIX 49 49 SER D 148 LEU D 153 5 6 HELIX 50 50 PRO D 155 ARG D 157 5 3 HELIX 51 51 TYR D 215 PHE D 219 5 5 HELIX 52 52 ASP D 220 PHE D 232 1 13 HELIX 53 53 SER D 247 GLY D 259 1 13 HELIX 54 54 GLU D 280 ALA D 291 1 12 HELIX 55 55 VAL D 302 VAL D 305 5 4 HELIX 56 56 SER D 320 HIS D 334 1 15 SHEET 1 AA 8 ILE A 103 ILE A 104 0 SHEET 2 AA 8 THR A 91 SER A 96 -1 O LEU A 94 N ILE A 103 SHEET 3 AA 8 ARG A 110 ASP A 121 1 N GLY A 111 O THR A 91 SHEET 4 AA 8 VAL A 132 ARG A 140 -1 O GLY A 133 N ASP A 121 SHEET 5 AA 8 ALA A 161 TYR A 167 -1 O ALA A 161 N ILE A 138 SHEET 6 AA 8 THR A 171 MET A 177 -1 O MET A 172 N LEU A 166 SHEET 7 AA 8 GLY A 180 ASP A 187 -1 O GLY A 180 N MET A 177 SHEET 8 AA 8 GLU A 192 ASP A 197 -1 O GLU A 192 N ASP A 187 SHEET 1 AB 5 GLY A 241 ALA A 242 0 SHEET 2 AB 5 ILE A 208 SER A 210 1 N TYR A 209 O GLY A 241 SHEET 3 AB 5 ILE A 261 TYR A 264 1 O ILE A 261 N SER A 210 SHEET 4 AB 5 VAL A 316 GLY A 319 -1 O VAL A 316 N TYR A 264 SHEET 5 AB 5 MET A 294 THR A 296 -1 O MET A 294 N GLY A 319 SHEET 1 BA 8 ILE B 103 ILE B 104 0 SHEET 2 BA 8 THR B 91 SER B 96 -1 O LEU B 94 N ILE B 103 SHEET 3 BA 8 ARG B 110 ASP B 121 1 N GLY B 111 O THR B 91 SHEET 4 BA 8 VAL B 132 ARG B 140 -1 O GLY B 133 N ASP B 121 SHEET 5 BA 8 ALA B 161 TYR B 167 -1 O ALA B 161 N ILE B 138 SHEET 6 BA 8 THR B 171 MET B 177 -1 O MET B 172 N LEU B 166 SHEET 7 BA 8 GLY B 180 ASP B 187 -1 O GLY B 180 N MET B 177 SHEET 8 BA 8 GLU B 192 ASP B 197 -1 O GLU B 192 N ASP B 187 SHEET 1 BB 5 GLY B 241 ALA B 242 0 SHEET 2 BB 5 ILE B 208 SER B 210 1 N TYR B 209 O GLY B 241 SHEET 3 BB 5 ILE B 261 TYR B 264 1 O ILE B 261 N SER B 210 SHEET 4 BB 5 VAL B 316 GLY B 319 -1 O VAL B 316 N TYR B 264 SHEET 5 BB 5 MET B 294 THR B 296 -1 O MET B 294 N GLY B 319 SHEET 1 CA 8 ILE C 103 ILE C 104 0 SHEET 2 CA 8 THR C 91 SER C 96 -1 O LEU C 94 N ILE C 103 SHEET 3 CA 8 ARG C 110 ASP C 121 1 N GLY C 111 O THR C 91 SHEET 4 CA 8 VAL C 132 ARG C 140 -1 O GLY C 133 N ASP C 121 SHEET 5 CA 8 ALA C 161 TYR C 167 -1 O ALA C 161 N ILE C 138 SHEET 6 CA 8 THR C 171 MET C 177 -1 O MET C 172 N LEU C 166 SHEET 7 CA 8 GLY C 180 LEU C 186 -1 O GLY C 180 N MET C 177 SHEET 8 CA 8 PHE C 193 ASP C 197 -1 O ILE C 194 N MET C 185 SHEET 1 CB 5 GLY C 241 ALA C 242 0 SHEET 2 CB 5 ILE C 208 SER C 210 1 N TYR C 209 O GLY C 241 SHEET 3 CB 5 ILE C 261 TYR C 264 1 O ILE C 261 N SER C 210 SHEET 4 CB 5 VAL C 316 GLY C 319 -1 O VAL C 316 N TYR C 264 SHEET 5 CB 5 MET C 294 THR C 296 -1 O MET C 294 N GLY C 319 SHEET 1 CC 2 LEU C 275 ARG C 276 0 SHEET 2 CC 2 ARG C 313 ALA C 314 -1 O ALA C 314 N LEU C 275 SHEET 1 DA 8 ILE D 103 ILE D 104 0 SHEET 2 DA 8 THR D 91 SER D 96 -1 O LEU D 94 N ILE D 103 SHEET 3 DA 8 ARG D 110 ASP D 121 1 N GLY D 111 O THR D 91 SHEET 4 DA 8 VAL D 132 ARG D 140 -1 O GLY D 133 N ASP D 121 SHEET 5 DA 8 LEU D 159 TYR D 167 -1 N VAL D 160 O ILE D 138 SHEET 6 DA 8 THR D 171 MET D 177 -1 O MET D 172 N LEU D 166 SHEET 7 DA 8 GLY D 180 LEU D 186 -1 O GLY D 180 N MET D 177 SHEET 8 DA 8 PHE D 193 ASP D 197 -1 O ILE D 194 N MET D 185 SHEET 1 DB 5 GLY D 241 ALA D 242 0 SHEET 2 DB 5 ILE D 208 SER D 210 1 N TYR D 209 O GLY D 241 SHEET 3 DB 5 ILE D 261 TYR D 264 1 O ILE D 261 N SER D 210 SHEET 4 DB 5 VAL D 316 GLY D 319 -1 O VAL D 316 N TYR D 264 SHEET 5 DB 5 MET D 294 THR D 296 -1 O MET D 294 N GLY D 319 SHEET 1 DC 2 LEU D 275 ARG D 276 0 SHEET 2 DC 2 ARG D 313 ALA D 314 -1 O ALA D 314 N LEU D 275 SITE 1 AC1 24 VAL B 17 MET B 18 GLY B 21 ARG B 22 SITE 2 AC1 24 GLY B 26 THR B 27 GLY B 28 GLU B 29 SITE 3 AC1 24 LEU B 30 THR B 31 HOH B2028 VAL D 17 SITE 4 AC1 24 MET D 18 GLY D 21 ARG D 22 ALA D 24 SITE 5 AC1 24 GLY D 26 THR D 27 GLY D 28 GLU D 29 SITE 6 AC1 24 LEU D 30 THR D 31 HOH D2024 HOH D2303 SITE 1 AC2 24 VAL A 17 MET A 18 GLY A 21 ARG A 22 SITE 2 AC2 24 ALA A 24 GLY A 26 THR A 27 GLY A 28 SITE 3 AC2 24 GLU A 29 LEU A 30 THR A 31 MET A 177 SITE 4 AC2 24 HOH A2085 HOH A2216 VAL C 17 GLY C 21 SITE 5 AC2 24 ARG C 22 GLY C 26 THR C 27 GLY C 28 SITE 6 AC2 24 GLU C 29 LEU C 30 THR C 31 MET C 177 CRYST1 67.176 83.012 277.234 90.00 90.00 90.00 P 21 21 21 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014886 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012046 0.000000 0.00000 SCALE3 0.000000 0.000000 0.003607 0.00000